Continue to advance DAPAR technology in a novel biopolymer-silk fibroin (SF). Have diverse expertise necessary to commercialize SF-based products but it is not limited to tissue engineering.

The first breakthrough SF-based E-gel is a vaccine-like product which can be applied directly and safely into the knee to prevent the progression of osteoarthritis.